---
title: "Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13.33, Implies 100% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295648514.md"
description: "Taysha Gene Therapies' average 12-month price target was raised to $13.33 by 12 analysts, up from $13.25. Based on the Aug. 11 close, this implies ~100% upside. The consensus rating remains 'Buy' with no Holds or Sells."
datetime: "2026-08-12T10:20:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295648514.md)
  - [en](https://longbridge.com/en/news/295648514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295648514.md)
generator: "portal-rs"
---

# Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $13.33, Implies 100% Upside

-   According to estimates from 12 analysts, Taysha Gene Therapies, Inc. stock's average price target has risen from $13.25 to $13.33, with forecasts ranging from $10 to $19 per share
-   Based on the Aug. 11 closing price, the updated target implies approximately 100% potential upside
-   Consensus rating remains at “Buy” across 12 covering analysts, with 12 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Taysha Gene Therapies, Inc. on the , and track all previous and future analyst recommendations for Taysha Gene Therapies, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md)

## Related News & Research

- [Taysha Gene Therapies, Inc. Stock 12‑Month Price Target Raised to $12.31, Implies 92% Upside](https://longbridge.com/en/news/290483883.md)
- [Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?](https://longbridge.com/en/news/296564505.md)
- [Starfighters Space, Inc. GAAP EPS of -$0.24](https://longbridge.com/en/news/296400745.md)
- [Is Wynn Resorts (WYNN) Undervalued As Al Marjan Hopes Meet A $100 Share Price?](https://longbridge.com/en/news/296486383.md)
- [CONMED (CNMD) Could Be 8% Overvalued Following Its Recent Rebound](https://longbridge.com/en/news/296318744.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**